JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on May 30, 2007; DOI: 10.1124/jpet.107.121988


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.121988v1
322/3/957    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sheng, W. S
Right arrow Articles by Peterson, P. K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sheng, W. S
Right arrow Articles by Peterson, P. K


Received for publication February 27, 2007.
Revised May 25, 2007.
Accepted for publication May 29, 2007.

Human Neural Precursor Cells Express Functional Kappa Opioid Receptors

Wen S Sheng 1*, Shuxian Hu 1, Greg Herr 2, Hsiao T Ni 2, Robert B Rock 1, Genya Gekker 1, James R Lokensgard 1, Phillip K Peterson 1

1 University of Minnesota 2 R&D Systems

* Address correspondence to: E-mail: sheng008{at}umn.edu

Abstract

Neural stem cells (NSCs) play an important role in the developing as well as adult brain. NSCs have been shown to migrate towards sites of injury in the brain and to participate in the process of brain repair. Like NSCs, cultured human neural precursor cells (NPCs) are self-renewing, multipotent cells capable of differentiating into neurons, astrocytes and oligodendrocytes and of migrating towards chemotactic stimuli. Cellular and environmental factors are important for NPC proliferation and migration. Expression of kappa opioid receptors (KORs) and mu opioid receptors (MORs) in murine embryonic stem cells and of MORs and delta opioid receptors in rodent neuronal precursors, as well as hippocampal progenitors has been reported by other investigators. In this study, we demonstrated robust expression of KORs in highly enriched (>90% nestin-positive) human fetal brain-derived NPCs. We found that KOR ligands, dynorphin1-17 and U50,488, but not dynorphin2-17, stimulated proliferation and migration of NPCs in a concentration-dependent manner. NPC proliferation was maximally stimulated at 10-14 M dynorphin1-17 and 10-12 M U50,488. The KOR selective antagonist, nor-binaltorphimine (nor-BNI), partially blocked the migratory and proliferative effects of KOR agonists supporting, at least in part, the involvement of a KOR-related mechanism. As has been described for rodent P19 embryonal carcinoma stem cells, retinoic acid treatment markedly suppressed KOR mRNA expression in human NPCs. Taken together, the results of this study suggest that activation of KORs alters functional properties of NPCs/NSCs that are relevant to human brain development and repair.


Key words: Dynorphins, Kappa opioid receptors, Migratrion, Neural precursor cells, Proliferation, U50,488





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.